Top Story

Cipla launches salmeterol/fluticasone metered-dose inhaler in Germany, Sweden

September 2, 2014

Cipla has launched its salmeterol/fluticasone metered-dose inhaler in Germany and Sweden, according to a press release.

The product will be branded as Serroflo in Germany and Salmeterol/Fluticasone Cipla in Sweden and will be available in a pressurized metered-dose inhaler with hydrofluoroalkane propellant in two strengths, 120 doses at 25/125 mcg salmeterol/fluticasone and 120 doses of 25/250 mcg salmeterol/fluticasone, the release said.

In the Journals

Asthma hospitalization rates decreased for American Indians, Alaska natives

September 2, 2014
American Indians and Alaska natives had a greater decrease in hospitalization rates for asthma compared with the general US population, according to recent study…

Xencor announces appointments

September 2, 2014
Xencor has appointed Debra Zack, MD, PhD, as vice president, clinical development, and Lloyd Rowland as senior vice president, chief compliance officer and general…
In the Journals

Partial asthma control therapy decreased use, sustained control

September 1, 2014
A treatment approach aimed at partial asthma control in adult patients significantly decreased medication use and associated costs and sustained asthma control when…
More News Headlines »
Meeting News Coverage Video

AAAAI adds five new guidelines to Choosing Wisely initiative

March 3, 2014
SAN DIEGO — The American Academy of Allergy, Asthma & Immunology today released the second list of…
More »